Showing results (81-90 of 134) with videos related to
Sort By:
Pageof 14
Oncoimmunology|March 7, 2022
Reprogramming monocyte-derived macrophages through caspase inhibitionPaul Chaintreuil, Lucie Laplane, Florian Esnault, et al.Oncotarget|June 26, 2014
Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell linesThomas Cluzeau, Alix Dubois, Arnaud Jacquel, et al.British Journal of Haematology|June 6, 2025
Dasatinib overcomes AML cells resistant to BCL2 inhibition by degrading MCL1Sylvain Garciaz, Camille Montersino, Maxence Bourgoin, et al.Oncotarget|May 12, 2012
BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patientsThomas Cluzeau, Guillaume Robert, Nicolas Mounier, et al.Pharmacology|April 3, 2024
HSPA8 Chaperone Complex Drives Chaperone-Mediated Autophagy Regulation in Acute Promyelocytic Leukemia Cell DifferentiationSreoshee Rafiq, Irene Mungure, Yara Banz, et al.Autophagy|August 28, 2015
Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic fluxSandy Giuliano, Yann Cormerais, Maeva Dufies, et al.Oncotarget|December 15, 2012
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinibOphélie Cassuto, Maeva Dufies, Arnaud Jacquel, et al.Journal of Medicinal Chemistry|January 18, 2017
In Vitro and in Vivo Evaluation of Fully Substituted (5-(3-Ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as Original Nucleoside Analogues to Circumvent Resistance in Myeloid MalignanciesHella Amdouni, Guillaume Robert, Mohsine Driowya, et al.Cancer Research|November 25, 2010
Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARCNina Fenouille, Alexandre Puissant, Maeva Dufies, et al.American Journal of Hematology|June 13, 2013
Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with AzacitidineThomas Cluzeau, Nicolas Mounier, Jean-Michel Karsenti, et al.Pageof 14